Monday, February 25, 2013

Intersect ENT Gets $30M

Menlo Park-based Intersect ENT, which develops sinus implants used to treat ear, nose and throat patients, said today that it has raised $30M in a Series D round of funding. The round was led by Norwest Venture Partners, and also included Kleiner Perkins Caufield & Byers, U.S. Venture Partners, PTV Sciences and Medtronic. The firm said the new funds will go towards commercialization efforts. The firm is led by Lisa Earnhardt. More information »